Mr. Mehta brings a wide-ranging global health care perspective to pharmaceutical and biotechnology asset management, investment research, and strategic advice.
Mr. Mehta’s work with the international division of Merck & Co. involved international strategic planning and competitor analysis. This global foundation prompted Wood MacKenzie & Company Inc. to invite him to establish a pharmaceutical research function in New York. This effort was expanded at S.G. Warburg & Company Inc. and led to the formation of his own advisory group, Mehta and Isaly.
Now known as Mehta Partners, the group provides strategic advisory, asset management, and institutional research services to clients worldwide. Mehta Partners have honed a specialty niche with an integrated global perspective aimed at understanding the critical success factors in the worldwide pharmaceutical and biotechnology sector, where for over 25 years, Mr. Mehta has advised senior managers and investors to capitalize upon emerging opportunities.
Mr. Mehta is a former Director at OSI Pharmaceuticals.
Educated at the University of Southern California (PharmD) and UCLA (MBA in international finance and marketing), he has worked with the pharmaceutical and biotechnology industry as well as private and public health care providers.